Orchid Pharma Ltd (ORCHPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 653435, "name": "Orchid Pharma", "stock_name": "Orchid Pharma", "full_name": "Orchid Pharma Ltd", "name_url": "stocks-analysis/orchid-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "510.00", "chg": -26.4, "chgp": "-4.92%", "dir": -1, "prev_price": "536.40", "mcapval": "2,628.00 Cr", "mcap": "Small Cap", "scripcode": 524372, "symbol": "ORCHPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE191A01027", "curr_date": "Mar 23", "curr_time": "", "bse_nse_vol": "60.3 k", "exc_status": "Active", "traded_date": "Mar 23, 2026", "traded_date_str": "2026 03 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3898514", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_mojoScore_3898514.png", "date": "2026-03-18 10:10:27", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis below reflects the stock’s current position as of 18 March 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective." }, { "title": "Orchid Pharma Falls 17.93%: 3 Key Factors Driving the Sharp Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-falls-1793-3-key-factors-driving-the-sharp-weekly-decline-3891731", "imagepath": "", "date": "2026-03-14 17:11:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> New 52-week low at Rs.503 amid gap down opening</p>\n <p><strong>4 Mar:</strong> Intraday low of Rs.550 on continued price pressure</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.508.70, down 17.93%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.619.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.508.70</div><div class=\"stat-change negative\">-17.93%</div></div>\n <div class=\"stat-item\"><div class=\"stat-la..." }, { "title": "Orchid Pharma Ltd Stock Falls to 52-Week Low of Rs.488.8", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-stock-falls-to-52-week-low-of-rs4888-3880450", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_priceRelatedfactors_3880450.png", "date": "2026-03-09 14:13:58", "description": "Orchid Pharma Ltd’s shares declined to a fresh 52-week low of Rs.488.8 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and operational metrics." }, { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3877909", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_mojoScore_3877909.png", "date": "2026-03-07 10:10:15", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Orchid Pharma Ltd Hits Intraday Low Amid Price Pressure on 4 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-intraday-low-amid-price-pressure-on-4-mar-2026-3870008", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_priceRelatedfactors_3870008.png", "date": "2026-03-04 13:00:53", "description": "Orchid Pharma Ltd experienced a significant intraday decline on 4 Mar 2026, touching a low of Rs 550, reflecting an 8.3% drop from previous levels. The stock underperformed its sector and broader market indices, continuing a downward trend amid persistent selling pressure and subdued market sentiment." }, { "title": "Orchid Pharma Ltd Opens with Significant Gap Down Amid Market Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-opens-with-significant-gap-down-amid-market-concerns-3865439", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_gapdown_3865439.png", "date": "2026-03-02 14:05:10", "description": "Orchid Pharma Ltd commenced trading today with a significant gap down, opening at an 18.85% lower price compared to its previous close, reflecting heightened market apprehension following recent developments. The stock hit a new 52-week low of Rs.503, underperforming its sector and broader indices amid sustained selling pressure." }, { "title": "Orchid Pharma Ltd Stock Hits 52-Week Low at Rs.503 Amid Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-stock-hits-52-week-low-at-rs503-amid-continued-downtrend-3864711", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_priceRelatedfactors_3864711.png", "date": "2026-03-02 12:00:54", "description": "Orchid Pharma Ltd’s shares touched a fresh 52-week low of Rs.503 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed both its sector and the broader market, reflecting persistent challenges in financial performance and valuation metrics." }, { "title": "Orchid Pharma Ltd Valuation Shifts Amidst Market Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-valuation-shifts-amidst-market-underperformance-3857215", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OrchidPharmaLtd_valuationdot_3857215.png", "date": "2026-02-26 08:00:34", "description": "Orchid Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle but significant change in price attractiveness. Despite this adjustment, the stock remains priced at a premium relative to its peers and historical averages, raising concerns for investors amid a challenging pharmaceutical sector backdrop." }, { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3852676", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OrchidPharmaLtd_mojoScore_3852676.png", "date": "2026-02-24 10:10:27", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 311, "sid": "653435", "stock_news_url": "https://www.marketsmojo.com/news/No announcements on in the last one month-653435" }, "announcements": [ { "caption": "Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (Amalgamating Company) With Orchid Pharma Limited (Amalgamated Company) And Their Respective Shareholders And Creditors (The Scheme) Under Regulation 30 Of SEBI (Listing Obligati", "datetime": "18-Mar-2026", "details": "Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited (Amalgamating Company) with Orchid Pharma Limited (Amalgamated Company) and their respective shareholders and creditors (the scheme) under regulation 30 of SEBI (Listing Obligations and Disclosure) Requirement Regulations 2015", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "16-Feb-2026", "details": "Transcript of Analysts/ Investors Earning call held with Public at large on February 12 2026 through tele-conferencing.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "12-Feb-2026", "details": "Audio Recording of the Analysts/Investors Earnings Call of Orchid Pharma Limited for the Quarter-3 ended on December 31 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12", "dt": "2012-09-13", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: New 52-week low at Rs.503 amid gap down opening

4 Mar: Intraday low of Rs.550 on continued price pressure

6 Mar: Week closes at Rs.508.70, down 17.93%

Read full news article

Orchid Pharma Ltd Stock Falls to 52-Week Low of Rs.488.8

2026-03-09 14:13:58

Orchid Pharma Ltd’s shares declined to a fresh 52-week low of Rs.488.8 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and operational metrics.

Read full news article

Orchid Pharma Ltd is Rated Strong Sell

2026-03-07 10:10:15

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Orchid Pharma Ltd Hits Intraday Low Amid Price Pressure on 4 Mar 2026

2026-03-04 13:00:53

Orchid Pharma Ltd experienced a significant intraday decline on 4 Mar 2026, touching a low of Rs 550, reflecting an 8.3% drop from previous levels. The stock underperformed its sector and broader market indices, continuing a downward trend amid persistent selling pressure and subdued market sentiment.

Read full news article

Orchid Pharma Ltd Opens with Significant Gap Down Amid Market Concerns

2026-03-02 14:05:10

Orchid Pharma Ltd commenced trading today with a significant gap down, opening at an 18.85% lower price compared to its previous close, reflecting heightened market apprehension following recent developments. The stock hit a new 52-week low of Rs.503, underperforming its sector and broader indices amid sustained selling pressure.

Read full news article

Orchid Pharma Ltd Stock Hits 52-Week Low at Rs.503 Amid Continued Downtrend

2026-03-02 12:00:54

Orchid Pharma Ltd’s shares touched a fresh 52-week low of Rs.503 today, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock has underperformed both its sector and the broader market, reflecting persistent challenges in financial performance and valuation metrics.

Read full news article

Orchid Pharma Ltd Valuation Shifts Amidst Market Underperformance

2026-02-26 08:00:34

Orchid Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle but significant change in price attractiveness. Despite this adjustment, the stock remains priced at a premium relative to its peers and historical averages, raising concerns for investors amid a challenging pharmaceutical sector backdrop.

Read full news article

Orchid Pharma Ltd is Rated Strong Sell

2026-02-24 10:10:27

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article